These authors showed that ADAM15B displays a significantly enhanced metalloprotease activity responsible for the shedding of ectodomains from transmembrane ADAM15 transmembrane substrates, including the shedding of fibroblast growth factor receptor 2 (FGFR2), which is involved in the development of breast cancer. Here, ADAM15 is linked to breast carcinoma.